Climate change

Compared to 2022, there was a 27.16% reduction in scope 1 and scope 2 emissions. This reduction was mainly due to the actions taken in transport between the Distribution Centers and the Pharmacies (page 96), and the increased consumption of energy from renewable sources.

In 2024, we will implement a pilot project with suppliers responsible for emissions from purchased goods and services to engage them in decarbonization strategies.

We reached 72% of operations supplied with renewable energy.

Measures adopted by the Company to monitor and reduce its emissions, including Scope 3 ones, as well as facing the threats of climate change.

Over the past few years, we have made significant progress on the ESG agenda and its integration into the routine analysis of scenarios, trends and factors that may positively or negatively impact our business. Climate-related risks are embedded in the Company’s Risk Matrix and are continuously monitored and evaluated by the Sustainability Committee and the […]

To calculate energy consumption from non-renewable sources, we consider the percentage of non-renewable electricity from utilities, using values from the National Energy Balance (BEN) for this calculation. Then, we add the consumption of non-renewable fuels (aviation kerosene, gasoline, diesel, and LPG). To calculate energy consumption from renewable sources, we consider the percentage of renewable electricity […]

We do not control energy consumption outside the organization. Therefore, this information is unavailable.

The Company’s energy intensity ratio is calculated based on the total energy consumption within the organization for the year, including the consumption of fuels and electricity. The denominator used is the built area, in square meters, of pharmacies, distribution centers, and the campus (office). We had a reduction in the ratio between 2022 and 2023 […]

As a result of our energy efficiency actions, in 2023, we had an average 18% reduction in the total electricity consumption of the network of pharmacies. However, there was no overall reduction in electricity consumption from 2022 to 2023, a reflection of the expansion and growth of our operation. Two methods were employed to calculate […]

Our approach to energy efficiency is based on two main fronts of action: • initiatives to reduce consumption at facilities, through the modernization of physical infrastructure and equipment, and awareness programs for our people and customers; • actions focused on increasing energy consumption from renewable sources. We maintain 100% of our lighting with LED bulbs […]

Check out the quantitative data on Scope 1 emissions from RD Saúde. Information on Scopes 2 and 3 emissions can be verified in disclosure 305-2 and 305-3, respectively. Also check out qualitative information about our climate journey in disclosure 305-5. Notas após tabelas: 1. Includes Kyoto GHG emissions in tCO2e (CO2, CH4, N2O, SF6, HFCs […]

Check out the quantitative data on Scope 2 emissions from RD Saúde. Information on Scopes 1 and 3 emissions can be verified in disclosures 305-1 and 305-3, respectively. Also check out qualitative information about our climate journey in disclosure 305-5. Notas após tabelas: 1. Includes Kyoto GHG emissions in tCO2e (CO2, CH4, N2O, SF6, HFCs […]

Check out the quantitative data on Scope 3 emissions from RD Saúde. Information about Scopes 1 and 2 emissions can be verified in disclosures 305-1 and 305-2. Also check out qualitative information about our climate journey in the TCFD tab of this panel. Emissão biogênica por escopo (tCO2e)1 2021 2022 2023 Escopo 1 24.596,19 29.051,29 […]

The intensity of emissions was 3.86 tCO2/t of products in 2023, which accounts for a 19% reduction compared to 2022. Notas: 1. Includes the categories: waste generated in operations, business travel, transport and distribution (downstream), use of goods and services sold, end-of-life treatment of products sold and investments. 2. Drugs, over-the-counter (OTC) drugs, and perfumery […]

Since 2021, we have been making progress in the use of electric trucks for B2B deliveries, i.e. the route from Distribution Centers to pharmacies. In addition, part of the fleet has switched to S10 diesel, a less carbon-intensive fuel. We continue working to strengthen the partnerships with last mile delivery companies to increase the use […]

(1) 972,421.53 GJ;(2) 47% grid electricity;(3) 94% renewable energy.

The Board of Directors is advised by the Sustainability Committee, which meets at least ten times a year to evaluate the evolution of actions and the performance of our sustainability strategy – which includes our climate change mitigation and adaptation plan. Advice resulting from these meetings is presented to the Board members. In addition to […]

In recent years, RD Saúde has made strides on the climate agenda and its integration into the routine analysis of scenarios and factors that may impact the Company, either positively or negatively. The Risk Committee, which advises the Board, identifies, measures, and monitors climate-related risks and opportunities together with business areas, in addition to defining […]

In 2023, we deepened our analysis of climate change-related risks and opportunities across all operations. The study aimed to identify the main physical and transition risks, as well as the main opportunities for the Company aligned with a low-carbon strategy. For physical risks, seven threats were considered: heat waves, river floods, vector proliferation, windstorms, landslides, […]

Climate-related risks and opportunities have influenced the development of the Company’s long-term vision, particularly in the definition of sustainability commitments for 2030, which impact and guide the strategy of our operations. Short-, medium-, and long-term financial planning related to direct and indirect expenses has also been influenced by climate risks and opportunities. The purchase of […]

RD Saúde has developed a consistent mitigation and adaptation strategy (page 95), which brings resilience to the business in the face of climate change: we have a high percentage of electricity consumption from renewable sources and have implemented energy-efficient solutions (page 96); we invested in training our own drivers and in optimizing processes to increase […]

We conducted a comprehensive climate risk identification and assessment study that covered all operating units in 2022 (RD Saúde Campus, 11 DCs, and 2,697 pharmacies). Physical and transition risks were identified with business areas and assessed based on their impact and probability, and classified according to the Company’s impact scale. The study considered SSP1-2.6 and […]

Risk review and monitoring at RD Saúde, including climate-related risks, are primarily conducted by the Risk Management Committee, an advisory body to the Board of Directors, which establishes regular and specific meetings to monitor risks according to their nature. This phase involves tracking key risk indicators (KRIs), the progress of action plans previously defined by […]

Since 2022, we have included climate-related risks in the Company’s risk matrix. The Risk Management team promotes continuous alignment with the Sustainability area and the business areas directly involved to address and monitor climate-related risks.

We assess risks and opportunities based on the impact on business and the likelihood of risks and opportunities occurring. Therefore, risks are classified by a combination of impact and likelihood, according to the matrix of risks and opportunities defined by the Company. The impact assessment uses quantitative (financial) and qualitative (image and reputation, health and […]

Risks related to GHG emissions include: i) physical risks: heat waves, river floods, vector proliferation, windstorms, landslides, sea level rise and fires; ii) transition risks: carbon pricing, cost of fossil fuels, exposure to climate litigation, non-compliance with climate-related financial disclosure requirements, non-compliance with requirements to disclose emissions and replace refrigerants with lower emission technologies, responsibility […]

In 2023, we revisited our sustainability commitments for 2030 and updated our climate-related targets. We made the following commitments: i) reduce Scope 1 and Scope 2 GHG emissions in line with the 1.5°C scenario, using 2021 as the base year; and ii) engage suppliers responsible for emissions from purchased goods and services (Category 1) to […]